Status:
NOT_YET_RECRUITING
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia
Lead Sponsor:
University College, London
Collaborating Sponsors:
King's College London
University of Melbourne
Conditions:
Staphylococcus Aureus Bacteremia
Staphylococcus Aureus Septicemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Having bacteria in the blood can be very dangerous. This is called bacteraemia (or bacteremia) or bloodstream infection. It can lead to problems across the whole body, which is what happens in sepsis....
Detailed Description
Staphylococcus aureus (S. aureus) bacteraemia/bloodstream infection (SAB) is associated with deep foci in a high proportion of cases, through local or haematogenous spread or seeding. Detecting infect...
Eligibility Criteria
Inclusion
- Adult (≥18 years of age)
- Staphylococcus aureus complex grown from ≥1 blood culture
- Symptoms of S. aureus bloodstream infection
- Admitted to a participating hospital at the time of eligibility assessment . Agrees to PET/CT
Exclusion
- Contraindication to PET/CT (including pregnancy/breast-feeding)
- PET/CT in the last 7 days or already planned to occur in the next 7 days
- Treating team deems enrolment in the study is not in the best interest of the patient
- Treating team believes that death is imminent and inevitable
- Patient is for end-of-life care and PET/CT is considered not appropriate
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
820 Patients enrolled
Trial Details
Trial ID
NCT05361135
Start Date
September 1 2023
End Date
July 1 2026
Last Update
May 15 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.